Exosome RNA Exosome RNA Research & Industry News
Chimeric antigen receptor (CAR)-based T-cell adoptive immunotherapy is a distinctively promising therapy for cancer. The engineering of CARs into T cells provides T cells with tumor-targeting capabilities and intensifies their cytotoxic activity through stimulated cell expansion and enhanced cytokine production. ...
Read More »Cell-derived exosomes make cell-based therapy more clinically controllable
